LSE - Delayed Quote GBp

Novacyt S.A. (NCYT.L)

42.00
+2.95
+(7.55%)
At close: May 23 at 4:35:23 PM GMT+1
Currency in GBP All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
19,630
19,630
10,621
21,040
92,603
Cost of Revenue
-12,444
-12,444
7,130
15,294
64,377
Gross Profit
32,074
32,074
3,491
5,746
28,226
Operating Expense
48,734
48,734
19,318
21,421
26,811
Operating Income
-16,660
-16,660
-15,827
-15,675
1,415
Net Non Operating Interest Income Expense
-2,087
-2,087
985
918
45
Pretax Income
-39,430
-39,430
-24,464
-20,053
-5,660
Tax Provision
-732
-732
-353
2,148
349
Net Income Common Stockholders
-41,758
-41,758
-28,292
-25,730
-9,728
Average Dilution Earnings
0
0
0
0
--
Diluted NI Available to Com Stockholders
-41,758
-41,758
-28,292
-25,730
-9,728
Basic EPS
-0.59
-0.59
-0.40
-0.36
-0.14
Diluted EPS
-0.59
-0.59
-0.40
-0.36
-0.14
Basic Average Shares
70,626.25
70,626.25
70,626.25
70,626.25
70,626.25
Diluted Average Shares
70,626.25
70,626.25
70,626.25
70,626.25
70,626.25
Total Operating Income as Reported
-37,343
-37,343
-25,449
-23,393
-3,916
Rent Expense Supplemental
--
--
340
477
397
Total Expenses
36,290
36,290
26,448
36,715
91,188
Net Income from Continuing & Discontinued Operation
-41,758
-41,758
-28,292
-25,730
-9,728
Normalized Income
-7,158.97
-7,158.97
-10,514.84
-11,297.75
1,863.61
Interest Income
3,034
3,034
3,421
779
396
Interest Expense
5,121
5,121
2,436
458
120
Net Interest Income
-2,087
-2,087
985
918
45
EBIT
-34,309
-34,309
-22,028
-19,595
-5,540
EBITDA
-34,309
-34,309
-12,385
-11,677
2,342
Reconciled Cost of Revenue
-12,444
-12,444
7,130
15,294
64,377
Reconciled Depreciation
-202
-202
9,643
7,918
7,882
Net Income from Continuing Operation Net Minority Interest
-38,698
-38,698
-24,111
-22,201
-6,009
Total Unusual Items Excluding Goodwill
-20,683
-20,683
-9,622
-7,663
-5,243
Total Unusual Items
-9,443
-9,443
-5,509
-2,507
-1,224
Normalized EBITDA
-24,866
-24,866
-6,876
-9,170
3,566
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-383.97
-383.97
-138.84
-1,915.75
-1,389.40
12/31/2021 - 11/1/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

5YL.F BrainCool AB (publ)
0.1276
-4.20%
 
FA0.F PExA AB (publ)
0.0150
-9.09%
 
0O5H.IL Elekta AB (publ)
48.74
-3.86%
 
ONCSM.IS Oncosem Onkolojik Sistemler Sanayi Ve Ticaret Anonim Sirketi
86.10
-1.43%
 
0K9P.IL GN Store Nord A/S
89.66
-1.48%
 
NEOLA.ST Neola Medical AB (publ)
2.5500
+1.19%
 
PHBA.BE Sonova Holding AG
56.00
-1.75%
 
RUA.L RUA Life Sciences plc
11.50
-1.08%
 
0QPY.IL Sonova Holding AG
262.05
-2.80%
 
HEART.ST Scandinavian Real Heart AB (Publ)
14.00
-1.06%